siMS Score: Simple Method for Quantifying Metabolic Syndrome.

Area of Science:

• Metabolic Syndrome Research
• Cardiovascular Risk Assessment
• Biostatistics

Background:

• Metabolic syndrome (MetS) is a cluster of conditions increasing cardiovascular disease risk.
• Current quantification methods for metabolic status and risk can be complex.
• There is a need for simpler, continuous scores for clinical utility.

Purpose of the Study:

• To evaluate the siMS score and siMS risk score as novel, continuous measures for metabolic status and risk.
• To assess the accuracy and simplicity of these new scores compared to existing methods.

Main Methods:

• The siMS score was developed using a formula incorporating waist-to-height ratio, glucose, triglycerides, systolic blood pressure, and HDL cholesterol.
• The siMS risk score was derived from the siMS score, incorporating age, gender, and family history of cardiovascular events.
• Validation involved 528 participants, comparing siMS scores against sum of z-scores, principal component analysis (PCA), and the Framingham score.

Main Results:

• The siMS score demonstrated high correlation (r=0.866) with sum of z-scores and (r=0.822) with PCA-derived scores.
• The siMS risk score showed medium to high correlation with the Framingham score across different age groups (0.667-0.835).

Conclusions:

• The siMS score and siMS risk score are accurate and simple tools for quantifying metabolic status and cardiovascular risk.
• Their ease of use and ability to track individual patient progress make them highly suitable for clinical practice and research.